Entrada Therapeutics, Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Entrada Therapeutics, Inc.
Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company’s Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Entrada Therapeutics, Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Entrada Therapeutics, Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Entrada Therapeutics, Inc. is TRDA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Entrada Therapeutics, Inc. has its primary listing on NASDAQ. You can trade Entrada Therapeutics, Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Entrada Therapeutics, Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Entrada Therapeutics, Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Entrada Therapeutics, Inc..